Patents Assigned to University
-
Patent number: 7556490Abstract: Methods and systems of stereolithography for building cost-efficient and time-saving multi-material, multi-functional and multi-colored prototypes, models and devices configured for intermediate washing and curing/drying is disclosed including: laser(s), liquid and/or platform level sensing system(s), controllable optical system(s), moveable platform(s), elevator platform(s), recoating system(s) and at least one polymer retaining receptacle. Multiple polymer retaining receptacles may be arranged in a moveable apparatus, wherein each receptacle is adapted to actively/passively maintain a uniform, desired level of polymer by including a recoating device and a material fill/remove system. The platform is movably accessible to the polymer retaining receptacle(s), elevator mechanism(s) and washing and curing/drying area(s) which may be housed in a shielded enclosure(s).Type: GrantFiled: July 30, 2004Date of Patent: July 7, 2009Assignee: Board of Regents, the University of Texas SystemInventors: Ryan Wicker, Francisco Medina, Christopher Elkins
-
Patent number: 7556855Abstract: An impact resistant device is provided comprising a support matrix and a plurality of energy absorbing elements operatively connected to the support matrix, each element comprising at least one ceramic material and at least one strain rate sensitive material. The impact resistant device can be worn as body armor to protect the wearer from high velocity projectiles.Type: GrantFiled: August 13, 2008Date of Patent: July 7, 2009Assignees: The Johns Hopkins University, University of North TexasInventors: Paul J. Biermann, Jack C. Roberts, Richard Reidy
-
Patent number: 7556810Abstract: The present invention relates to compositions comprising cupredoxins, and their use to inhibit angiogenesis in mammalian cells, tissues, and animals, and particularly the angiogenesis that accompanies tumor development and particularly in humans. Specifically, the present invention relates to compositions comprising the cupredoxin(s), and or peptides that are variants, derivatives or structural equivalents of cupredoxins, which retain the ability to inhibit angiogenesis in mammalian cells, tissues or animals. These compositions may be peptides or pharmaceutical compositions, among others. The compositions of the invention may be used to treat any pathological condition that has as a symptom or cause, inappropriate angiogenesis, and particularly inappropriate angiogenesis related to tumor development.Type: GrantFiled: July 19, 2006Date of Patent: July 7, 2009Assignee: The Board of Trustees of the University of IlinoisInventors: Rajeshwari R. Mehta, Brad N. Taylor, Tohru Yamada, Craig W. Beattie, Tapas K. Das Gupta, Ananda M. Chakrabarty
-
Patent number: 7557349Abstract: In a bolometer-type THz-wave detector 1 in a micro-bridge structure in which a temperature detecting portion 14 (diaphragm) including a bolometer thin film 7 is supported by a supporting portion 13 in a state suspended from a circuit substrate, a member (dielectric cover 11) made of a dielectric material for efficiently collecting a THz wave is added to an upper part of the temperature detecting portion 14, and when a refractive index of the dielectric cover 11 is n, thickness is t, and a wavelength of the THz wave is ?, a setting is made so as to have at >?, and a gap between the dielectric cover 11 and the temperature detecting portion 14 is set at integral multiples of ?/2. By this arrangement, an absorptance of the THz wave can be improved using a structure and manufacturing method of a bolometer-type infrared detector, and a high-performance bolometer-type THz-wave detector can be manufactured with a high yield.Type: GrantFiled: March 27, 2008Date of Patent: July 7, 2009Assignees: NEC Corporation, The University of Tokyo, National Institute of Information and Communications TechnologyInventors: Naoki Oda, Susumu Komiyama, Iwao Hosako
-
Patent number: 7556117Abstract: Hood lift mechanisms for reversibly increasing the energy absorption capability at appropriate force levels of a vehicle closure includes a vehicle closure; an active material in operative communication with the vehicle closure, wherein the active material comprises a shape memory alloy, a ferromagnetic shape memory alloy, a shape memory polymer, a magnetorheological fluid, an electroactive polymer, a magnetorheological elastomer, an electrorheological fluid, a piezoelectric material, an ionic polymer metal composite, or combinations comprising at least one of the foregoing active materials; and an activation device in operative communication with the active material, wherein the activation device is operable to selectively apply an activation signal to the active material and effect a reversible change in a property of the active material, wherein the reversible change results in an increased clearance distance between the vehicle closure and an underlying component.Type: GrantFiled: September 20, 2006Date of Patent: July 7, 2009Assignees: GM Global Technology Operations, Inc., The University of MichiganInventors: Alan L. Browne, Nancy L. Johnson, Kenneth A. Strom, Diann Brei, Jonathan E. Luntz, Brian M. Barnes
-
Patent number: 7557144Abstract: The present invention generally relates to diseases or conditions modulated by undesired protein expression. In one aspect, the methods provide for administration to a mammal, particularly a human, of a therapeutically effective amount of a carbocyclic aryl compound capable of modulating that undesired protein expression. Assays for detecting compounds having desired therapeutic capacity are also provided.Type: GrantFiled: March 11, 2000Date of Patent: July 7, 2009Assignee: The Johns Hopkins UniversityInventors: Pamela L. Zeitlin, Saul Brusilow
-
Patent number: 7557309Abstract: A data and power distribution system for an electrical busway is provided. The system has a base plate and a data channel located adjacent to or proximate to the base plate. The data channel is structured to receive a number of data transport devices therein. An electrical busway is coupled to the base plate and a power channel is located adjacent to or proximate to the base plate. The power channel is structured to receive the electrical busway therein. The data channel is located proximate to the power channel and the base plate is a unitary component. The base plate may have a number of locations on the base plate that are structured to receive fasteners in order to directly attach the base plate to a mounting surface.Type: GrantFiled: June 7, 2007Date of Patent: July 7, 2009Assignee: Universal Electric CorporationInventors: Steven L. Ross, Brian L. Hilgert, Russell Griffith
-
Patent number: 7557251Abstract: This invention relates to relates to methods for producing gossypol acetic acid co-crystals and (?)-gossypol acetic acid co-crystals. The invention also relates to pharmaceutical compositions comprising gossypol acetic acid co-crystals and (?)-gossypol acetic acid co-crystals and the use of gossypol acetic acid co-crystals and (?)-gossypol acetic acid co-crystals for inducing apoptosis in cells and for sensitizing cells to the induction of apoptotic cell death.Type: GrantFiled: March 29, 2007Date of Patent: July 7, 2009Assignee: The Regents of the University of MichiganInventors: Shaomeng Wang, Jianyong Chen, John F. W. Keana, Ming Guo
-
Patent number: 7557434Abstract: A power electronic package includes: first and second high thermal conductivity insulating non-planar substrates; and a plurality of electronic components mounted on each of the substrates. The substrates are coupled each other at a plurality of bonding regions so that mechanical separation between the substrates is controlled by the number of the bonding regions, an arrangement of the bonding regions, a shape of each bonding region, and a material of the bonding regions. The mechanical separation provides a net axially-directed compressive force in the electronic components.Type: GrantFiled: August 29, 2006Date of Patent: July 7, 2009Assignees: DENSO CORPORATION, University of Cambridge, The University of SheffieldInventors: Rajesh Kumar Malhan, C. Mark Johnson, Jeremy Rashid
-
Patent number: 7557367Abstract: The invention provides methods and devices for fabricating printable semiconductor elements and assembling printable semiconductor elements onto substrate surfaces. Methods, devices and device components of the present invention are capable of generating a wide range of flexible electronic and optoelectronic devices and arrays of devices on substrates comprising polymeric materials. The present invention also provides stretchable semiconductor structures and stretchable electronic devices capable of good performance in stretched configurations.Type: GrantFiled: June 2, 2005Date of Patent: July 7, 2009Assignee: The Board of Trustees of the University of IllinoisInventors: John A. Rogers, Dahl-Young Khang, Etienne Menard
-
Patent number: 7557086Abstract: Method and peptide for regulating cellular activity includes a panel of synthesized peptides that have biological effects on inhibiting or enhancing cellular activity. Selected peptides can be used as therapy to reduce and/or inhibit, or initiate and/or enhance, an inflammatory response in a subject.Type: GrantFiled: January 23, 2007Date of Patent: July 7, 2009Assignees: The United States of America as represented by the U.S. Department of Veterans Affairs, The United States of America as represented by the Oregon Health & Science UniversityInventors: Steven H. Hefeneider, Sharon L. McCoy
-
Patent number: 7557184Abstract: The duplex DNA of chromosomes is replicated in a multicomponent process. A helicase unwinds the DNA, a replicase synthesizes new DNA, and primase repeatedly synthesizes new primed starts on the lagging strand. The present invention is directed to the genes from Gram positive bacterium encoding these proteins, and their characterization.Type: GrantFiled: October 28, 2002Date of Patent: July 7, 2009Assignee: The Rockefeller UniversityInventors: Michael E. O'Donnell, Dan Zhang, Richard Whipple
-
Patent number: 7558612Abstract: Real-time imaging of a moving object such as the heart uses fast imaging with steady precession (FISP) traversing spirals in k-space. After flipping nuclear spins in the object within a slice to be imaged, signals are read out from the nuclear spins while applying read-out magnetic field gradients whereby read-out signals traverse spirals in k-space. Thereafter, the zero moment and first moment of the read-out gradients are driven to zero quickly so that fast imaging with steady state precession is realized without banding artifacts. Motion compensated rewinders are applied after the read-out magnetic field gradients which can be integral with the read-out gradients or comprise separate compensation lobes.Type: GrantFiled: April 16, 2002Date of Patent: July 7, 2009Assignee: The Board of Trustees of the Leland Stanford Junior UniversityInventor: Craig H. Meyer
-
Patent number: 7556596Abstract: The invention is a novel adaptive CT-compatible brachytherapy applicator with remotely-controlled radial and longitudinal motion radioactive source lumen shields that can be manipulated by the radiation oncologist to optimize the dose distribution to the target and normal tissue structures for brachytherapy procedures.Type: GrantFiled: July 20, 2005Date of Patent: July 7, 2009Assignee: Board of Regents The University of Texas SystemInventors: Firas Mourtada, John Horton, Patricia Eifel, Anuja Jhingran, Ira Spool
-
Patent number: 7557097Abstract: Compounds that function as lamprey attractants and methods.Type: GrantFiled: November 20, 2004Date of Patent: July 7, 2009Assignee: Regents of the University of MinnesotaInventors: Peter W. Sorensen, Thomas R. Hoye, Jared M. Fine, Vadims Dvornikovs, Jizhou Wang, Lance A. Vrieze
-
Patent number: 7556927Abstract: The invention provides a novel human Mab Fab, cloned by phage display, and its use in diagnostic and therapeutic methods. In particular the invention provides a method for analyzing the OxLDL components of atherosclerotic plaques in vivo and a means to determine their relative pathology. As the method is based on a human Fab rather than a mouse Mab, the progress or regression of the disease may be monitored over time. The antibody may also be used for the analysis of surgical or serum samples ex vivo for the presence of OxLDL. The antibody may also be used to target therapeutic agents to the site of atherosclerotic plaques or may have use as a therapeutic agent itself.Type: GrantFiled: November 11, 2003Date of Patent: July 7, 2009Assignee: The Regents of the University of CaliforniaInventors: Joseph L. Witztum, Sotirios Tsimikas, Wulf Palinski, Peter X. Shaw
-
Patent number: 7556789Abstract: This invention provides: 1) methods for the identification of broad spectrum holins with a high level of nonenzymatic activity in membranes; 2) conditions required for maintaining and increasing the anti-microbial and anti-pest efficacy of holins in gene fusions; 3) a method for effective targeting of holins expressed in plants through use of leader peptide to direct the holin protein in the plant apoplast and xylem; 4) methods for the control of bacterial and fungal diseases of plants and control of insect and nematode pests that attack plants by expression of gene fusion involving holins, C-terminal additions and leader peptides, and optionally, endolysis; 5) methods for increasing the shelf of cut flowers, and 6) transgenic plants useful for the production of novel antimicrobial proteins based upon holins.Type: GrantFiled: May 14, 2004Date of Patent: July 7, 2009Assignee: Central Michigan University Board of TrusteesInventor: Bradley D. Fahlman
-
Patent number: 7557197Abstract: The human soluble neuropilin-1 (sNRP) polyadenylation signal (sNRP-poly(A)), situated downstream of the GT splice donor site of intron 12 of the full-length neuropilin-1 gene, also functions as the termination codon for sNRP. This 17 nucleotide sequence efficiently facilitates addition of poly(A) tails to RNAs expressed in cells. The present invention shows that this optimally succinct sequence has similar activity to the SV40 polyadenylation signal that is currently used in expression vectors. By using this shorter dual termination/polyadenylation signal and avoiding the need for large and cumbersome polyadenylation signals, expression vectors may be engineered to carry considerably larger genes.Type: GrantFiled: January 28, 2005Date of Patent: July 7, 2009Assignee: Oregon Health & Science UniversityInventors: J. Timothy Stout, Trevor McFarland, Peter J. Francis, Binoy Appukuttan
-
Patent number: 7557392Abstract: In a thin-layer chemical transistor having a metal/solid electrolyte/semiconductor structure, the materials of which the solid electrolyte and semiconductor layers are made comprise organic solvent-soluble compounds. The transistor can be fabricated solely by solvent processes, typically printing techniques including ink jet printing.Type: GrantFiled: August 9, 2005Date of Patent: July 7, 2009Assignees: Osaka University, Shin-Etsu Chemical Co., Ltd.Inventors: Tomoji Kawai, Masateru Taniguchi, Ikuo Fukui
-
Patent number: 7556942Abstract: Tumor suppressor genes (TSGs) play a major role in the pathogenesis of human cancers. Here, a new TSG designated hippo (hpo) is described, and the human homolog mst2 is identified as an additional TSG. hpo as a gene that regulates both cell proliferation and cell death in Drosophila, and encodes a Ste-20 family protein kinase that binds to and phosphorylates the tumor suppressor protein Salvador (Sav), which is known to interact with the Warts (Wts) protein kinase. Loss of hpo results in elevated transcription of the cell cycle regulator cyclin E and the cell-death inhibitor diap1, leading to increased proliferation and reduced apoptosis. Further, hpo, sav, and wts define a pathway that regulates diap1 at the transcriptional level. A human homolog of hpo completely rescues the overgrowth phenotype of Drosophila hpo? mutants.Type: GrantFiled: July 15, 2004Date of Patent: July 7, 2009Assignee: Board of Regents, The University of Texas SystemInventor: Duojia Pan